Circulation, Vol 82, 2027-2034, Copyright © 1990 by American Heart Association
WD Weaver, CE Fahrenbruch, DD Johnson, AP Hallstrom, LA Cobb and MK Copass
One hundred ninety-nine patients with out-of-hospital cardiac arrest
persisted in ventricular fibrillation after the first defibrillation
attempt and were then randomly assigned to receive either epinephrine or
lidocaine before the next two shocks. The resulting electrocardiographic
rhythms and outcomes for each group of patients were compared for each
group and also compared with results during the prior 2 years, a period
when similar patients primarily received sodium bicarbonate as initial
adjunctive therapy. Asystole occurred after defibrillation with threefold
frequency after repeated injection of lidocaine (15 of 59, 25%) compared
with patients treated with epinephrine (four of 55, 7%) (p less than 0.02).
There was no difference in the proportion of patients resuscitated after
treatment with either lidocaine or epinephrine (51 of 106, 48% vs. 50 of
93, 54%) and in the proportion surviving (18, 19% vs. 21, 20%),
respectively. Resuscitation (64% vs. 50%, p less than 0.005) but not
survival rates (24% vs. 20%) were higher during the prior 2-year period in
which initial adjunctive drug treatment for persistent ventricular
fibrillation primarily consisted of a continuous infusion of sodium
bicarbonate. The negative effect of lidocaine or epinephrine treatment was
explained in part by their influence on delaying subsequent defibrillation
attempts. Survival rates were highest (30%) in a subset of patients who
received no drug therapy between shocks. We conclude that currently
recommended doses of epinephrine and lidocaine are not useful for improving
outcome in patients who persist in ventricular fibrillation.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation
Department of Medicine, University of Washington, Seattle.
This article has been cited by other articles:
![]() |
Part 7.2: Management of Cardiac Arrest Circulation, December 13, 2005; 112(24_suppl): IV-58 - IV-66. [Full Text] [PDF] |
||||
![]() |
P. Dorian, D. Cass, B. Schwartz, R. Cooper, R. Gelaznikas, and A. Barr Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation N. Engl. J. Med., March 21, 2002; 346(12): 884 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ewy and J. P. Ornato Emergency cardiac care: introduction J. Am. Coll. Cardiol., March 15, 2000; 35(4): 825 - 880. [Full Text] [PDF] |
||||
![]() |
B. N. Singh Initial Antiarrhythmic Drug Therapy During Resuscitation from Sudden Cardiac Death: A Time for a Fundamental Change in Strategy? Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(1): 3 - 9. [PDF] |
||||
![]() |
P. J. Kudenchuk, L. A. Cobb, M. K. Copass, R. O. Cummins, A. M. Doherty, C. E. Fahrenbruch, A. P. Hallstrom, W. A. Murray, M. Olsufka, and T. Walsh Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation N. Engl. J. Med., September 16, 1999; 341(12): 871 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
A A J Adgey and P W Johnston Approaches to modern management of cardiac arrest Heart, October 1, 1998; 80(4): 397 - 401. [Full Text] |
||||
![]() |
D A Chamberlain Antiarrhythmic drugs in resuscitation Heart, October 1, 1998; 80(4): 408 - 411. [Full Text] |
||||
![]() |
G. H. Bardy, F. E. Marchlinski, A. D. Sharma, S. J. Worley, R. M. Luceri, R. Yee, B. D. Halperin, C. L. Fellows, T. S. Ahern, D. A. Chilson, et al. Multicenter Comparison of Truncated Biphasic Shocks and Standard Damped Sine Wave Monophasic Shocks for Transthoracic Ventricular Defibrillation Circulation, November 15, 1996; 94(10): 2507 - 2514. [Abstract] [Full Text] |
||||
![]() |
U M Guly, R G Mitchell, R Cook, D J Steedman, and C E Robertson Paramedics and technicians are equally successful at managing cardiac arrest outside hospital BMJ, April 29, 1995; 310(6987): 1091 - 1094. [Abstract] [Full Text] |
||||
![]() |
Adult Advanced Cardiac Life Support JAMA, October 28, 1992; 268(16): 2199 - 2241. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |